Nicholas W. Baxter - 12 Oct 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Nicholas Baxter/
Issuer symbol
LEXX
Transactions as of
12 Oct 2022
Net transactions value
$0
Form type
4
Filing time
13 Oct 2022, 12:49:40 UTC
Previous filing
08 Mar 2022
Next filing
25 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 11,000 12 Oct 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +18,200 +154% $0.000000 30,000 12 Oct 2022 Common Shares 18,200 $1.96 Direct
holding LEXX Stock Options 1,500 12 Oct 2022 Common Shares 1,500 $5.31 Direct
holding LEXX Stock Options 6,500 12 Oct 2022 Common Shares 5,000 $7.08 Direct
holding LEXX Stock Options 8,400 12 Oct 2022 Common Shares 1,900 $6.23 Direct
holding LEXX Stock Options 11,800 12 Oct 2022 Common Shares 3,400 $3.39 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.